Rheumatoid

Rheumatoid - most related articles:

- Rheumatoid arthritis risk higher in people with high birth weight - 4.3
- Rheumatoid arthritis increases heart attack risk 60% - 4.2
- Rheumatoid arthritis rising among women in US - 4.1
- UCB's Cimzia approved for rheumatoid arthritis adults - 4.1
- Rheumatoid arthritis drug masitinib found effective - 3.9
- Asthma can be treated with Tocilizumab rheumatoid arthritis drug - 3.7
- Herpes zoster or shingles risk more with rheumatoid arthritis medicines - 3.7
- Bone density related to bone erosion in rheumatoid arthritis patients - 3.3
- New rheumatoid arthritis criteria aim to recognise RA early - 3.2
- Rheumatoid arthritis worse in women - 3.1

Rheumatoid articles

Asthma can be treated with Tocilizumab rheumatoid arthritis drug
Asthma sufferers now can be treated with a drug used to treat rheumatoid arthritis, revealed by researchers in a new study.

Rheumatoid arthritis and psoriasis medications lowers diabetes risk
Certain rheumatoid arthritis and psoriasis medications are associated with reduced diabetes risk, revealed by researchers. 2 disease-modifying antirheumatic drugs, TNF inhibitors and hydroxychloroquine, are associated with a reduced risk for the development of diabetes in psoriasis and rheumatoid arthritis patients

Tai chi helps improve mental health and prevent falls in elderly
T'ai chi has particular health benefits for older people, including helping to prevent falls and improving mental wellbeing, reveals a review published ahead of print in the British Journal of Sports Medicine.

Rheumatoid arthritis increases heart attack risk 60%
The risk of having a heart attack is 60 per cent higher just a year after a patient has been diagnosed with rheumatoid arthritis, according to research published in the December issue of the Journal of Internal Medicine.

Homeopathy consultations can benefit arthritis patients
In a study published in the journal Rheumatology, researchers found that arthritis patients significantly benefited when they received homeopathy alongside conventional treatment over a period of 6 months.

Rheumatoid arthritis signaling protein may reverse Alzheimer's disease
A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reports.

New rheumatoid arthritis criteria aim to recognise RA early
New criteria for rheumatoid arthritis (RA), published in the Annals of Rheumatic Diseases, could prevent thousands of people from developing disabling late stage disease, by redefining how RA should be classified.

Alcohol may reduce severity of rheumatoid arthritis symptoms
Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research published today. It is the first time that this effect has been shown in humans.

Rheumatoid arthritis incidence on the rise in women
The incidence of rheumatoid arthritis (RA) in women has risen during the period of 1995 to 2007, according to a newly published study by researchers from the Mayo Clinic.

RA patients and doctors differ on disease severity assessment
A novel study by researchers at the University of California, San Francisco found that nearly one-third of Rheumatoid Arthritis (RA) patients differed from their physicians in assessment of their disease severity.

Blood test can predict rheumatoid arthritis early
Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset.

Actemra, tocilizumab approved for Rheumatoid Arthritis
Genentech, Inc. , a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.

Shoe choice may cause foot pain
Women who make poor shoe choices early in life suffer with foot pain in later years, revealed by researchers. The new study is published in the October issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

Bone density related to bone erosion in rheumatoid arthritis patients
A new study has examined the relationship between two rheumatoid arthritis related processes i.e. focal erosions and osteoporosis, in the hopes of providing insight into the underlying pathophysiology of RA-related bone disease.

Rheumatoid arthritis drug masitinib found effective
A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well tolerated and effective, revealed by researchers in BioMed Central's journal Arthritis Research and Therapy.

Exercise improves ability in rheumatoid arthritis patients
Undertaking a supervised exercise programme can have beneficial effects on functional status and physical function, reduce the need for daily corticosteroid and anti-inflammatory intake and improve levels of depression and anxiety in people with rheumatoid arthritis (RA).

Genes and smoking play role in rheumatoid arthritis
Recent genetic studies have revealed several new sites of genes that are risk factors for developing rheumatoid arthritis (RA), revealed by researchers in the June issue of Arthritis & Rheumatism.

UCB's Cimzia approved for rheumatoid arthritis adults
UCB announced that the U.S. Food and Drug Administration (FDA) approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

Arthritis a most common cause of disability in Americans
Nearly 48 million Americans have a disability, an increase of three million from 1999, and arthritis tops the list of most common causes of disability, according to an article published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report (MMWR).

Herpes zoster or shingles risk more with rheumatoid arthritis medicines
Use of certain medications known as monoclonal anti tumor necrosis factor a (TNF-a) antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for herpes zoster (shingles), the painful infection characterized by blisters, according to a study in the February 18 issue of JAMA.

Rheumatoid arthritis worse in women
Women appear to suffer more from rheumatoid arthritis (RA) than men. This is revealed in research published in BioMed Central's open access journal Arthritis Research and Therapy.

Stem cells to repair the body
Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.

Rheumatoid arthritis rising among women in US
After four decades on the decline, rheumatoid arthritis is on the upswing among women in the United States. That's the finding presented by Mayo Clinic investigators at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals in San Francisco.

Rheumatoid arthritis risk higher in people with high birth weight
People who have a birth weight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birth weight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases.

Researchers discover a pathway to turn off immune system
University of Minnesota researchers have discovered a new way to turn genes off in human T cells, a type of white blood cell that helps the immune system fight infections. Turning off genes, through a process known as mRNA decay, is important for regulating the body's immune response after fighting infection.

1000 Genomes Project to support disease studies
An international research consortium announced the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of at least a thousand people from around the world to create the most detailed and medically useful picture to date of human genetic variation.

Arthritis drug celecoxib can adversely affect heart rhythm
COX-2 inhibitors like Celecoxib have come under scrutiny lately due to adverse cardiovascular side-effects stemming from COX-2 reduction. In both fruit fly and rat models, researchers reveal another adverse effect of Celecoxib; this drug can induce arrhythmia. More interestingly, this effect is independent of the COX-2 enzyme.

Test for targeted therapy in acute myeloid leukemia
An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer.

28 Rheumatoid articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
6.84